|   | |
| Identifiers | |
|---|---|
| 
 | |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C24H23ClN6O2 | 
| Molar mass | 462.94 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
PSB-KK1415 is an experimental drug that acts as a potent and selective agonist for the cannabinoid-like NAGly receptor, also known as GPR18. It has potential applications in studying the immune system and development of cancer. [1]